These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36107519)

  • 41. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant melanoma of the male urethra with increased 5-
    Aoki Y; Soma T; Nakamura Y; Fukui N; Sakai Y; Kageyama Y
    IJU Case Rep; 2019 Jul; 2(4):215-217. PubMed ID: 32743417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels.
    Ikuta Y; Nakatsura T; Kageshita T; Fukushima S; Ito S; Wakamatsu K; Baba H; Nishimura Y
    Clin Cancer Res; 2005 Nov; 11(22):8079-88. PubMed ID: 16299239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurocutaneous melanosis associated with malignant leptomeningeal melanoma in an adult: clinical significance of 5-S-cysteinyldopa in the cerebrospinal fluid---case report.
    Shinno K; Nagahiro S; Uno M; Kannuki S; Nakaiso M; Sano N; Horiguchi H
    Neurol Med Chir (Tokyo); 2003 Dec; 43(12):619-25. PubMed ID: 14723271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
    Wakamatsu K; Ito S; Fujita K
    Acta Derm Venereol; 1990; 70(5):367-72. PubMed ID: 1980967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.
    Benathan M
    Melanoma Res; 1996 Jun; 6(3):183-9. PubMed ID: 8819121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microdialysis of 5-S-cysteinyldopa from interstitial fluid in cutaneous human melanoma transplanted to athymic mice.
    Blomquist L; Dizdar N; Karlsson M; Kågedal B; Ossowicki H; Pettersson A; Smeds S
    Melanoma Res; 1991; 1(1):23-32. PubMed ID: 1822767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of DOPA-loading on glutathione-dependent 5-S-cysteinyldopa genesis in melanoma cells in vitro.
    Mojamdar M; Ichihashi M; Mishima Y
    J Invest Dermatol; 1982 Mar; 78(3):224-6. PubMed ID: 6799583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
    Hansson C; Edholm LE; Agrup G; Rorsman H; Rosengren AM; Rosengren E
    Clin Chim Acta; 1978 Sep; 88(3):419-27. PubMed ID: 699334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantification of melanoma-associated molecules in plasma/serum of melanoma patients.
    Hauschild A; Gläser R; Christophers E
    Recent Results Cancer Res; 2001; 158():169-77. PubMed ID: 11092044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Definitive diagnosis of early malignant melanoma lesions by the quantitative analysis of 5-S-cysteinyldopa in the tissue and touch fluorescence method].
    Kanematsu S; Morishima T
    Nihon Hifuka Gakkai Zasshi; 1989 Jun; 99(7):783-91. PubMed ID: 2511360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
    Wakamatsu K; Ito S; Fujita K
    Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):270-2. PubMed ID: 78645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
    Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
    Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
    Graef V; Paul E
    Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
    Marnot D; Decaux F; Berthelot P; Kalis B; Jardillier JC; Warren L
    Cancer Detect Prev; 1983; 6(1-2):303-10. PubMed ID: 6411338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased serum levels of 5-S-cysteinyldopa and intercellular adhesion molecule-1 in a patient with a uterine amelanotic metastasis from a primary vaginal malignant melanoma.
    Suenaga Y; Katabuchi H; Okamura H; Kageshita T; Ono T
    Gynecol Oncol; 1999 Jan; 72(1):107-10. PubMed ID: 9889040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnosis of amelanotic malignant melanoma by means of the fluorescence method (Falck & Hillarp) and determination of 5-S-cysteinyldopa in the lesions].
    Morishima T; Fukada E; Nagashima N
    Nihon Hifuka Gakkai Zasshi; 1983 Jan; 93(1):51-4. PubMed ID: 6408288
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of malignant melanoma with dacarbazin (DTIC-DOME) with special reference to urinary excretion of 5-S-cysteinyldopa.
    Jönsson PE; Agrup G; Arnbjörnsson E; Hafström L; Rorsman H
    Cancer; 1980 Jan; 45(2):245-8. PubMed ID: 6153150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.